期刊
DRUG RESISTANCE UPDATES
卷 71, 期 -, 页码 -出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.drup.2023.101002
关键词
Adenocarcinoma; Tumor; Treatment; Chemotherapy; Resistance
This review summarizes the treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs. Although the molecular mechanisms of drug resistance in adenocarcinoma vary from one organ to another, there are universal targets that could potentially reverse drug resistance.
Adenocarcinoma is a common type of malignant tumor, originating from glandular epithelial cells in various organs, such as pancreas, breast, lung, stomach, colon, rectus, and prostate. For patients who lose the opportunity for radical surgery, medication is available to provide potential clinical benefits. However, drug resistance is a big obstacle to obtain desired clinical prognosis. In this review, we provide a summary of treatment strategies and drug resistance mechanisms in adenocarcinoma of different organs, including pancreatic cancer, gastric adenocarcinoma, colorectal adenocarcinoma, lung adenocarcinoma, and prostate cancer. Although the under-lying molecular mechanisms involved in drug resistance of adenocarcinoma vary from one organ to the other, there are several targets that are universal for drug resistance in adenocarcinoma, and targeting these molecules could potentially reverse drug resistance in the treatment of adenocarcinomas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据